BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260827T083000
DTEND;TZID=America/Los_Angeles:20260827T130000
DTSTAMP:20260727T194001Z
CREATED:20260727T193946Z
LAST-MODIFIED:20260727T194001Z
UID:10001132-1787819400-1787835600@www.califesciences.org
SUMMARY:Advances in Neuropsychiatry: Emerging Biology and Therapeutics
DESCRIPTION:The Frontiers in Neuropsych Symposium is a fully virtual event highlighting the latest advances in novel neuroscience therapeutics. The symposium brings together experts from across the field to examine innovative approaches to complex neuropsychiatric disorders\, spanning early biological discovery through clinical development. \nDesigned for scientists\, clinicians\, and industry leaders\, the event provides a forum for discussing emerging research and therapies that address significant unmet needs and aim to improve patient outcomes worldwide. \nKey Topics:\n\nBiomarker- and genomics-guided drug discovery in schizophrenia\nMental illness and PTSD\nDevelopmental and rare disorders associated with psychosis\nSleep\, behavioral wellness\, and recovery\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advances-in-neuropsychiatry-emerging-biology-and-therapeutics/
LOCATION:https://www.califesciences.org/event/advances-in-neuropsychiatry-emerging-biology-and-therapeutics/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260827T120000
DTEND;TZID=America/Los_Angeles:20260827T130000
DTSTAMP:20260730T164058Z
CREATED:20260730T164058Z
LAST-MODIFIED:20260730T164058Z
UID:10001140-1787832000-1787835600@www.califesciences.org
SUMMARY:Genetically Engineered Mouse Models & Their Applications
DESCRIPTION:Genetically engineered mouse models (GEMMs) are the backbone of modern preclinical drug development. With the world’s largest GEMM repository and a fully integrated CRO platform\, GemPharmatech offers researchers an unmatched toolkit for moving from target biology to IND-enabling studies. \nIn this lunch and learn\, Jun Wang\, PhD\, Senior Scientific Director at GemPharmatech\, walks through real preclinical case studies across oncology\, metabolic disease\, neurology\, and immunology — illustrating how model selection\, study design\, and integrated CRO capabilities translate into more translatable data and more defensible go/no-go decisions. \nSpeaker Info\nJun Wang\, PhD \nSenior Scientific Director \nDr. Jun Wang has over 15 years of experience in biomedical research. Prior to joining GemPharmatech\, he served as an Associate Director of Research at Explora Biolabs/Charles River. He has extensive experience with genetically engineered mouse models for drug discovery in various therapeutic areas. Dr. Wang holds a Ph.D. in Developmental Neurobiology from the City of Hope and received his postdoctoral training in pediatric brain cancer research from the Sanford Burnham Prebys Medical Discovery Institute. \nAgenda\n\n​12:00 PM- 12:15 PM: Welcome – Lunch\n12:15- 1:00: Discussion\n​1:00 PM – 2:00 PM: Office Hours\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/genetically-engineered-mouse-models-their-applications/
LOCATION:5270 California Ave\, 5270 California Ave\, Irvine\, CA\, 92617\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260827T160000
DTEND;TZID=America/Los_Angeles:20260827T190000
DTSTAMP:20260416T160203Z
CREATED:20260416T160203Z
LAST-MODIFIED:20260416T160203Z
UID:10001067-1787846400-1787857200@www.califesciences.org
SUMMARY:Beakers & Brews
DESCRIPTION:
URL:https://www.califesciences.org/event/beakers-brews-sd-aug27/
LOCATION:CASA Campus Point\, 4242 Campus Point Ct\, San Diego\, CA\, 92121
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/04/Beakers-Brews-SD-Web-Card.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260901
DTEND;VALUE=DATE:20260903
DTSTAMP:20260728T183123Z
CREATED:20260728T183123Z
LAST-MODIFIED:20260728T183123Z
UID:10001138-1788220800-1788393599@www.califesciences.org
SUMMARY:Hub and Specialty Pharmacy Models West
DESCRIPTION:The Hub and Specialty Pharmacy Model conference series returns to sunny San Diego\, CA at the stunning Estancia La Jolla Hotel & Spa. Demand for agile\, scalable and innovative programs are at an all time high as market dynamics continue to evolve and regulatory changes remains unclear. This event brings together top industry experts to equip you with cutting-edge technologies and actionable insights to enhance patient outcomes. Hub and Specialty Pharmacy Models West is the premier event for professionals seeking unparalleled networking opportunities and expert-driven content to refine their hub strategies and elevate their patient services suite. \n\nCLS members receive a 10% discount to attend the conference. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/hub-and-specialty-pharmacy-models-west/
LOCATION:Estancia La Jolla Hotel & Spa\, 9700 N Torrey Pines Rd\, La Jolla\, 92037\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T070000
DTEND;TZID=America/Los_Angeles:20260902T080000
DTSTAMP:20260820T212048Z
CREATED:20260820T212048Z
LAST-MODIFIED:20260820T212048Z
UID:10001164-1788332400-1788336000@www.califesciences.org
SUMMARY:Accelerating Pre-Clinical Large-Molecule Screening with an Integrated DMPK/ADME Approach
DESCRIPTION:In early discovery and development\, accurate bioanalytical methods\, combined with CMC manufacturability\, are essential for driving molecule screening and assessing developability within a DMPK/ADME framework. \nIn this webinar\, BioDuro will present case studies spanning multiple novel modalities including antibodies\, bispecific antibodies\, ADC (Antibody Drug Conjugate)\, and APC (Antibody Peptide Conjugate) therapeutics. The presentation will focus on three key areas: \n\nLC-MS/MS\, ELISA\, and Gyrolab as comparable bioanalytical methods for ADC and antibody PK analysis\nTransgenic mouse PK as a rapid screening approach\nADME screening strategies for peptides\, linkers\, and payloads in ADC programs.\n\nThese case studies demonstrate how an integrated DMPK/ADME platform can accelerate preclinical screening and improve decision-making for early-stage large-molecule programs. While bioanalysis of biologics and conjugated therapeutics presents unique challenges due to matrix complexity\, molecular heterogeneity\, and evolving analytical requirements\, innovative bioanalytical strategies can generate robust\, reliable data that enable confident candidate selection and successful program progression. \nWhat you will learn: \n\nUnderstand the strengths and applications of LC-MS/MS\, ELISA\, and Gyrolab for consistent pharmacokinetic analysis of antibodies and ADC\nLearn how transgenic mouse pharmacokinetic models can serve as a rapid and efficient approach for early candidate screening\nExplore ADME screening strategies for peptides\, linkers\, and payloads to support the discovery and optimization of ADC programs\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/accelerating-pre-clinical-large-molecule-screening/
LOCATION:https://www.califesciences.org/event/accelerating-pre-clinical-large-molecule-screening/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T140000
DTEND;TZID=America/Los_Angeles:20260902T190000
DTSTAMP:20260630T163410Z
CREATED:20260612T163414Z
LAST-MODIFIED:20260630T163410Z
UID:10001105-1788357600-1788375600@www.califesciences.org
SUMMARY:California Leadership Forum
DESCRIPTION:The California Leadership Forum brings together CEOs\, executives\, and policymakers for an afternoon of candid conversation on the issues defining the life sciences sector in 2026. From the evolving political landscape to what it means to lead during a period of profound transformation\, the Forum offers a unique opportunity to engage with the leaders shaping the future of California life sciences.
URL:https://www.califesciences.org/event/california-leadership-forum/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:California Life Sciences,Curated Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/06/California-Leadership-Forum.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260908T140000
DTEND;TZID=America/Los_Angeles:20260908T150000
DTSTAMP:20260824T155308Z
CREATED:20260824T155308Z
LAST-MODIFIED:20260824T155308Z
UID:10001167-1788876000-1788879600@www.califesciences.org
SUMMARY:The Massive Scale of GLP-1s: Evolving Health\, Healthcare and Markets
DESCRIPTION:GLP-1 receptor agonists. Never before has one therapeutic class promised such a seismic shift in the health of Americans—or the U.S. and global economies. Already established as cornerstone therapies in diabetes and obesity\, Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide bring in billions of dollars each year. And the drugs are only expanding their reach: semaglutide has also been approved to lower cardiovascular risk and tirzepatide for sleep apnea\, with ongoing research showing promise in treating conditions as far afield as addiction\, Alzheimer’s disease and cancer. \nSo it’s no wonder the class is having a larger\, structural effect on U.S. health systems and consumer markets\, from a rise in direct-to-consumer purchasing options to debates over pricing and coverage. How can companies—both established providers of GLP-1s and those looking to break onto the exploding market—navigate this unprecedented territory? What will it mean for patients? \nThis panel will focus on understanding how the incredible health gains driven by GLP-1s can reach as many people as possible and how these drugs might evolve the broader healthcare system. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-massive-scale-of-glp-1s-biospace/
LOCATION:https://www.califesciences.org/event/the-massive-scale-of-glp-1s-biospace/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260909T113000
DTEND;TZID=America/Los_Angeles:20260909T180000
DTSTAMP:20260824T160656Z
CREATED:20260824T160656Z
LAST-MODIFIED:20260824T160656Z
UID:10001170-1788953400-1788976800@www.califesciences.org
SUMMARY:Bicoastal Medical Devices & Diagnostics Symposium
DESCRIPTION:Medical Device & Diagnostics 2026 is a premier bicoastal event that brings together innovators\, industry leaders\, healthcare professionals\, investors\, and entrepreneurs to shape the future of medical technology. Explore breakthrough medical devices\, cutting-edge diagnostics\, and emerging technologies through inspiring keynotes\, expert panel discussions\, and meaningful networking opportunities. \nHosted on both the East and West Coasts\, this event offers greater accessibility while delivering the same world-class content and collaborative experience at each location. Whether you join us in Baltimore or San Diego\, you’ll connect with the minds driving innovation\, gain actionable insights into regulatory and market trends\, and discover the partnerships that will define the next generation of healthcare. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/bicoastal-medical-devices-diagnostics-symposium/
LOCATION:10918 Technology Pl\, 10918 Technology Pl\, San Diego\, CA\, 92127\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T100000
DTEND;TZID=America/Los_Angeles:20260910T120000
DTSTAMP:20260824T160958Z
CREATED:20260824T160958Z
LAST-MODIFIED:20260824T160958Z
UID:10001171-1789034400-1789041600@www.califesciences.org
SUMMARY:Navigating Regulatory Pathways for Health Innovation
DESCRIPTION:Demystify your regulatory pathway with this essential session: \n\nUnderstand the role of regulatory agencies like FDA and Health Canada in ensuring product safety and efficacy.\nDefine your solution’s classification and intended use to chart a clear regulatory pathway.\nLearn strategies for leveraging predicate devices and exploring 510(k) and De Novo submissions.\nNavigate global market entry requirements and compliance frameworks.\nDevelop a proactive regulatory strategy to minimize barriers and align with business goals.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/navigating-regulatory-pathways-for-health-innovation/
LOCATION:10918 Technology Pl\, 10918 Technology Pl\, San Diego\, CA\, 92127\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260910T140000
DTEND;TZID=America/New_York:20260910T150000
DTSTAMP:20260820T211414Z
CREATED:20260820T211352Z
LAST-MODIFIED:20260820T211414Z
UID:10001162-1789048800-1789052400@www.califesciences.org
SUMMARY:The Insider's Guide to Leveraging Podcasts\, Webinars and Thought Leadership Programs
DESCRIPTION:How do you turn podcasts\, webinars and thought leadership programs into meaningful visibility for your organization or clients? \nJoin BioSpace’s Managing Editor\, Director of Insights and Vice President of Marketing for an inside look at how PR\, communications and marketing teams can successfully leverage webinars\, podcasts and integrated content campaigns to elevate executive voices\, share industry expertise and engage key biotech and pharma audiences. \nIn this interactive discussion\, our team will break down the differences between available thought leadership opportunities\, explain how content is selected and developed\, and share what makes a pitch stand out. You’ll gain practical guidance on identifying the right opportunities\, aligning topics with our audience interests\, preparing speakers for successful appearances and maximizing the value of participation before\, during and after an event. \nWhether you’re promoting an executive thought leader\, launching a new initiative or building long-term brand awareness\, you’ll walk away with actionable tips to help secure stronger opportunities and better outcomes. Attendees will also have the opportunity to ask questions during a live Q&A with the BioSpace editorial\, insights and marketing teams. \nWhat to expect: \n\nGain strong practical understanding of how BioSpace podcasts and webinars are developed\, produced and marketed\nGet an insider’s perspective on what makes a guest\, topic or pitch stand out to our team\nDiscover how to identify thought leadership opportunities that align with your marketing and communications goals\nLearn how to prepare executives for stronger\, more engaging appearances\nGet practical tips for extending the reach and impact of your content before\, during and after an event\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/insiders-guide-leveraging-thought-leadership-programs/
LOCATION:https://www.califesciences.org/event/insiders-guide-leveraging-thought-leadership-programs/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T160000
DTEND;TZID=America/Los_Angeles:20260910T173000
DTSTAMP:20260824T161626Z
CREATED:20260824T161601Z
LAST-MODIFIED:20260824T161626Z
UID:10001172-1789056000-1789061400@www.califesciences.org
SUMMARY:Entity Choice Selection
DESCRIPTION:A practical\, no-jargon session breaking down C-Corps\, LLCs\, Partnerships\, and Sole Proprietorships — so founders can choose the entity that actually fits their liability needs\, tax situation\, and growth plans. We’ll cover the real trade-offs. \n\nC-Corporation\nPartnership\nLLC\nSole Proprietorship\nPros / Cons\n\nLiability protection\nSelf-employment tax\nEntity-level tax\nGood for investors\nExit strategy\n\n\nTax Filing Requirements and due dates\nSalaries treatment & deferred compensation\nValuation questions\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/entity-choice-selection/
LOCATION:10918 Technology Pl\, 10918 Technology Pl\, San Diego\, CA\, 92127\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T170000
DTEND;TZID=America/Los_Angeles:20260910T190000
DTSTAMP:20260810T212922Z
CREATED:20260810T212922Z
LAST-MODIFIED:20260810T212922Z
UID:10001151-1789059600-1789066800@www.califesciences.org
SUMMARY:MedTech CEO Networking Reception
DESCRIPTION:Designed exclusively for manufacturing company CEOs and senior executives\, these intimate events provide an opportunity to briefly step away from day-to-day demands and engage with peers on the timely and relevant issues facing you and your company and shaping the future of our industry. \nWhat you’ll gain: \n\nConnect with fellow medtech leaders in a small\, invitation-only setting designed to foster candid conversations and valuable new relationships.\nHear unfiltered insights from industry CEOs as they discuss the opportunities\, challenges\, and strategic decisions keeping leadership teams focused today—from innovation and growth to policy\, investment\, talent\, board management\, the impact of AI and the evolving healthcare landscape.\nGet an exclusive and brief preview of The MedTech Conference\, including opportunities designed specifically for CEOs and executive leadership\, while helping shape the conversations that will continue in Boston this October.\n\nThe program will feature a discussion with: \n\nQuentin Blackford\, President & Chief Executive Officer\, iRhythm \nLisa Earnhardt\, EVP and Group President\, Medical Devices\, Abbott\nModerator: Philip Oettinger\, Partner\, Wilson Sonsini \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/medtech-ceo-networking-reception/
LOCATION:Wilson Sonsini\, One Market Plaza Spear Tower\, 19th Floor\, San Francisco\, CA\, 94105\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260910T173000
DTEND;TZID=America/Los_Angeles:20260910T200000
DTSTAMP:20260803T161858Z
CREATED:20260803T161858Z
LAST-MODIFIED:20260803T161858Z
UID:10001144-1789061400-1789070400@www.califesciences.org
SUMMARY:How to Build a Working AI System in Life Sciences
DESCRIPTION:Everyone in life sciences has been told to use AI. Most have not been shown properly how. \n​Due to popular demand\, we’re hosting this session in person in SF. This is a 90-minute hands-on session for life sciences professionals who want to actually understand what AI systems do and leave having built one. \n​We’ll cover the mental model that makes everything else click: how AI systems process information\, why the tools you use behave the way they do\, and how to write instructions that produce reliable outputs. Then you’ll build a working assistant (and not agent – we’ll tell you why not) around a task from your own workflow. No coding experience required. \n​Bring a laptop\, your LLM of choice\, and one problem you’d like AI to help with. You’ll leave with something that works. \n​Who this is for: R&D professionals\, clinicians\, post-docs\, research scientists\, and anyone in life sciences who works with AI tools and wants to understand them better. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/build-ai-system-life-sciences-sf/
LOCATION:201 Third Street\, 201 Third Street\, San Francisco\, CA\, 94103\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260912T100000
DTEND;TZID=America/Los_Angeles:20260912T150000
DTSTAMP:20260810T232740Z
CREATED:20260810T232740Z
LAST-MODIFIED:20260810T232740Z
UID:10001153-1789207200-1789225200@www.califesciences.org
SUMMARY:Kits Cubed STEM Fair 2026
DESCRIPTION:Kits Cubed is excited to host their 6th Annual STEM Fair at Oakland Technical High School! This free event will be full of learning\, exploration\, and discovery! \nCome enjoy energy filled games\, hands-on science activities\, and live music. This event will kick off the school year with STEM fun as they prepare for future programming and events for Bay Area scientists. \nKits Cubed is partnering with California Life Sciences\, Chabot Space and Science Center\, the Lawrence Hall of Science\, the Crucible and many more to ensure an amazing STEM-filled day! \nLEARN MORE» \nHosted by:
URL:https://www.califesciences.org/event/kits-cubed-stem-fair-2026/
LOCATION:Oakland Technical High School\, 4351 Broadway Avenue\, Oakland\, CA\, 94611\, United States
CATEGORIES:Community Initiatives & Programs
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260917
DTSTAMP:20260730T164423Z
CREATED:20260730T164423Z
LAST-MODIFIED:20260730T164423Z
UID:10001141-1789344000-1789603199@www.califesciences.org
SUMMARY:Biotech Symposium 2026
DESCRIPTION:The Charles River Biotech Symposium unites drug development professionals in an interactive setting to discuss the nonclinical development of biotherapeutics\, including regulatory issues and innovative approaches to problem-solving. The collegial spirit of this meeting creates exceptional opportunities for information sharing and networking. \nRegister today to save your seat for an event aimed to inspire\, educate\, and connect you with the opinion leaders shaping the future of biotherapeutics. Learn from their successes and failures\, how unexpected obstacles were overcome\, and hear stories of their interactions with the FDA. \nDon’t miss “Cross the Barrier: Targeted Tissue Delivery of Biologics” the optional workshop on Sunday\, September 13\, 2026 when making your travel plans. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/biotech-symposium-2026/
LOCATION:San Diego Mission Bay Resort\, 1775 East Mission Bay Drive\, San Diego\, CA\, 92109\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260914T083000
DTEND;TZID=America/Los_Angeles:20260914T153000
DTSTAMP:20260715T195021Z
CREATED:20260715T194903Z
LAST-MODIFIED:20260715T195021Z
UID:10001126-1789374600-1789399800@www.califesciences.org
SUMMARY:From the Laboratory to Leadership | San Diego
DESCRIPTION:In the life sciences\, technical expertise often leads to a promotion into management. But leading people requires an entirely new set of skills\, and even your highest-performing scientists can struggle without the right support.  \nFrom the Laboratory to Leadership was designed specifically for this critical transition. Across four interactive sessions\, participants learn to:  \n\nDiscover and develop their leadership strengths  \nLead confidently in dynamic\, fast-paced environments  \nRun effective meetings and coach for performance  \nSet expectations\, delegate effectively\, and adapt to different personality styles  \nAmplify the performance outcomes of their teams \n\nProgram dates: September 14\, September 28\, October 12\, and October 26 \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/lab-to-leadership-sd-2026/
LOCATION:SD Tech by Alexandria  Building 1\, 9605 Scranton Road\, San Diego\, CA\, 92121\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T093000
DTEND;TZID=America/Los_Angeles:20260915T103000
DTSTAMP:20260806T202448Z
CREATED:20260806T202448Z
LAST-MODIFIED:20260806T202448Z
UID:10001146-1789464600-1789468200@www.califesciences.org
SUMMARY:When Lyocakes Go Bad - How to Identify & Fix It
DESCRIPTION:Join our webinar to discover how you can identify and fix any issues in your own batches. Using different examples of lyocake defects\, Biopharma Group’s Senior Scientist\, Niloofar Ganji\, will explain how to identify these issues\, even when they’re not visible to the naked eye\, and share effective strategies for resolving them. \nThe session will cover key techniques such as Freeze Drying Microscopy (FDM) analysis and understanding collapse temperature\, helping you optimize primary drying conditions and prevent defects before they occur. \nKey Benefits of Attending\nYou’ll discover how to: \n\nIdentify & Classify Lyophilization Defects: Learn best practices for recognizing and naming various defects that can occur during freeze drying.\nUtilize Advanced Analytical Tools: Discover how to use instruments like MicroPress to detect defects that aren’t visible to the naked eye or reflected in standard performance assays.\nFix & Optimize: Understand how to rectify identified issues using cutting-edge tools like Lyostat5 and Lyotherm3 to pinpoint necessary process adjustments.\n\nand receive: \n\nReal-World Insights: Gain valuable takeaways from an in-depth case study demonstrating practical solutions.\nInteractive Q&A: Get your questions answered by an expert in the field.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/when-lyocakes-go-bad-how-to-identify-fix-it/
LOCATION:https://www.califesciences.org/event/when-lyocakes-go-bad-how-to-identify-fix-it/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T100000
DTEND;TZID=America/Los_Angeles:20260915T110000
DTSTAMP:20260817T172045Z
CREATED:20260817T165621Z
LAST-MODIFIED:20260817T172045Z
UID:10001159-1789466400-1789470000@www.califesciences.org
SUMMARY:Exploring New Frontiers in In Vivo CAR-T Therapy
DESCRIPTION:Live Webinar: Exploring New Frontiers in In Vivo CAR-T Therapy \n📅 Date: Sept 15\, 2026\n🕙 Time: 10 AM PT | 1 PM ET | 5 PM GMT | 7 PM CET \nFeatured Talk 1: “Targeted-LNP Technology for Precision Genetic Medicine” – Joe Yu\, PhD\nThis talk will introduce practical strategies to overcome these bottlenecks and optimize tLNP development from early-stage discovery to scalable manufacturing. \nFeatured Talk 2: “From Delivery Vehicle to Cells: Enabling In Vivo CAR Development with Integrated End-to-End Solutions” – Hui Yu\, PhD\nExplore integrated solutions for targeted delivery\, LNP characterization\, and CAR detection to accelerate next-generation in vivo CAR therapy development. \n 
URL:https://www.califesciences.org/event/exploring-new-frontiers-in-in-vivo-car-t-therapy/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T110000
DTEND;TZID=America/Los_Angeles:20260915T120000
DTSTAMP:20260820T211046Z
CREATED:20260820T211046Z
LAST-MODIFIED:20260820T211046Z
UID:10001161-1789470000-1789473600@www.califesciences.org
SUMMARY:The Regulatory Foundation: Getting It Right Before You Build
DESCRIPTION:For early-stage MedTech founders\, regulatory strategy isn’t a late-stage checkbox\, it’s a foundational decision that shapes everything downstream\, from your FDA pathway to your funding story to how you eventually get paid. \nIn this fireside conversation\, former FDA reviewer Sam Murray walks through the decisions that matter most before you build. We’ll cover how your intended use and your own claims define your regulatory reality\, how to read your risk class and map the right pathway (510(k)\, De Novo\, or PMA)\, the low-cost early moves that get you FDA’s read before you’re locked in\, and what SBIR/STTR reviewers actually want to see in your commercialization plan. We’ll close with why regulatory and reimbursement timing should be planned together and how getting it right early is the cheapest course-correction there is. \nBring your questions for a live audience Q&A to wrap. \nREGISTER» \nAbout the Speakers\nSam Murray\, Head of Regulatory & Quality\, PRIA Healthcare\nSam leads PRIA’s regulatory affairs and quality division\, providing strategic leadership to life sciences and medical device companies navigating complex regulatory pathways and quality system challenges. He advises executive leadership teams\, investors and diligence teams\, product development organizations\, and regulatory and quality leaders on regulatory strategy\, global product approvals\, and scalable quality system design across the full product lifecycle. \nSam’s background spans medical devices\, diagnostics\, combination products\, and software-enabled technologies. His primary areas of expertise include U.S. regulatory strategy\, global regulatory submissions including European MDR and IVDR implementation\, quality system development and remediation\, design controls\, risk management\, and regulatory authority engagement. He has led and supported regulatory programs that enabled global marketing authorizations and reduced time to commercialization. In addition to founding and leading an independent regulatory and quality consultancy supporting medical device manufacturers globally\, Sam has also held senior leadership roles at Advanced Instruments and Formlabs\, where he built and scaled global regulatory and quality organizations\, established multi-site quality systems\, and led acquisition due diligence\, assessing regulatory risk\, quality system maturity\, and post-close integration needs. Sam previously served as a medical device investigator with the U.S. Food and Drug Administration\, conducting domestic and international inspections and driving compliance and enforcement actions. \n​Suzy Engwall\, Senior Director\, Global Business Development and Strategic Growth\, PRIA Healthcare\nSuzy is a healthcare innovation and commercialization executive\, who has spent nearly two decades helping MedTech companies navigate the complex journey from product development to market adoption. She has extensive experience across the MedTech ecosystem\, spanning startups\, accelerators\, health systems\, GPOs\, and international markets\, connecting clients with strategic guidance and expertise they need to successfully commercialize their technologies. \nBefore joining PRIA\, Suzy founded and led HealthTech Strategies\, a consulting firm specializing in U.S. market entry strategy\, GPO contracting\, and commercialization. She previously served as VP of Early MedTech Development at Alira Health\, advising emerging MedTech companies on clinical and commercial strategy. As National Director of the Innovation Lab at the Innovation Institute\, she managed a multi hospital innovation program that brought 21 products to market\, including licensing agreements with CVS and OrthoPediatrics. She designed and facilitated accelerator-style programming\, including hackathons\, innovation sprints\, and pitch showcases\, and guided participants through the process of refining\, patenting\, and launching their inventions. \nA recognized thought leader and speaker across the MedTech ecosystem\, Suzy has served as director and mentor for the Founder Institute HealthTech program\, was on advisory boards for ASU’s Edson College of Nursing and Health Innovation\, the UC Riverside Design Thinking Program\, and currently serves on multiple startup advisory boards\, including the Board of Directors of Actuated Medical. \nHosted by:
URL:https://www.califesciences.org/event/the-regulatory-foundation-university-lab-partners/
LOCATION:https://www.califesciences.org/event/the-regulatory-foundation-university-lab-partners/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260915T110000
DTEND;TZID=America/Los_Angeles:20260915T140000
DTSTAMP:20260727T194655Z
CREATED:20260727T194655Z
LAST-MODIFIED:20260727T194655Z
UID:10001133-1789470000-1789480800@www.califesciences.org
SUMMARY:Scientist.com's Vendor Discovery Day - San Francisco
DESCRIPTION:Join Scientist.com for our 2026 San Francisco Vendor Discovery Day and showcase your innovations! Connect with top researchers\, expand your network and elevate your brand’s visibility. Don’t miss this opportunity to unlock new collaborations and drive your business forward. See you in September! \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/scientist-coms-vendor-discovery-day-san-francisco/
LOCATION:685 Gateway Blvd\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260916
DTEND;VALUE=DATE:20260918
DTSTAMP:20260603T233444Z
CREATED:20260603T233444Z
LAST-MODIFIED:20260603T233444Z
UID:10001097-1789516800-1789689599@www.califesciences.org
SUMMARY:Cell & Gene Therapy Symposium
DESCRIPTION:
URL:https://www.califesciences.org/event/cell-gene-therapy-symposium/
LOCATION:Salk Institute for Biological Studies\, 10010 N Torrey Pines Rd\, La Jolla\, CA\, 92037\, United States
CATEGORIES:California Life Sciences,Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/06/Cell-Gene-Therapy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260916T080000
DTEND;TZID=America/Los_Angeles:20260916T090000
DTSTAMP:20260820T212315Z
CREATED:20260820T212315Z
LAST-MODIFIED:20260820T212315Z
UID:10001165-1789545600-1789549200@www.califesciences.org
SUMMARY:Regulatory Shifts Ahead: Preparing for FDA Changes and EU Pharmaceutical Reform
DESCRIPTION:Regulatory change is underway on two fronts. FDA review practice has evolved meaningfully over recent review cycles\, and the EU has finalized a sweeping reform of its pharmaceutical legislation that has not yet entered into force. For sponsors filing an IND with the FDA\, preparing an EMA submission\, or planning a Phase II expansion into the EU\, this session offers an early look at what’s changing and how to get ahead of it. \nIn this session\, William Lian (BioDuro) covers the current FDA IND landscape: where IND submission changes\, how Clinical Holds get resolved\, and why getting CMC right early is the key to avoiding them. William will also introduce FDA’s evolving expectations for nonclinical development\, including initiatives such as the increased use of New Approach Methodologies (NAMs). \nMiranda van Bodegom (DADA Consultancy) turns to the EU\, where the change is legal\, not procedural. She unpacks several developments under what EMA itself has called “the most significant overhaul of the regulatory framework in over two decades”. Miranda will introduce upcoming changes covering development and registration phases\, pharmacovigilance and regulatory aspects\, the new approach to environmental risk\, and the expanded the use of Master Files. \nJoin BioDuro and DADA Consultancy to find out what’s changing\, and what sponsors should be preparing for. \nWhat you will learn: \n\nWhy FDA Clinical Holds happen\, and how CMC readiness prevents them\nWhether FDA’s NAMs shift changes your preclinical testing plan\nWhether you qualify for a Master File under the EU’s pharmaceutical legislation reform\nHow to navigate the European “green legislation”\nHow to position your pipeline now\, ahead of these changes taking full effect\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/preparing-for-fda-changes-and-eu-pharmaceutical-reform/
LOCATION:https://www.califesciences.org/event/preparing-for-fda-changes-and-eu-pharmaceutical-reform/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260917T080000
DTEND;TZID=America/Los_Angeles:20260918T170000
DTSTAMP:20260625T182515Z
CREATED:20260625T182515Z
LAST-MODIFIED:20260625T182515Z
UID:10001115-1789632000-1789750800@www.califesciences.org
SUMMARY:PCC West | Pharmaceutical Compliance Congress West
DESCRIPTION:Transform your compliance strategy at PCC West – the West Coast’s most dynamic gathering of life science compliance leaders. This September 10-11 at Hilton La Jolla in San Diego\, immerse yourself in cutting-edge insights that will revolutionize how you navigate today’s complex regulatory landscape. Discover game-changing strategies for FDA compliance\, master DOJ enforcement trends\, and unlock the potential of AI while mitigating risks. Engage with visionary experts tackling real-world challenges in HCP engagement\, patient interactions\, and program optimization. You’ll leave equipped with actionable intelligence and powerful connections that elevate your compliance program from reactive to revolutionary. \n\nCLS members receive a 10% discount on registration for the event. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/pcc-west-2026/
LOCATION:HILTON LA JOLLA TORREY PINES\, 10950 N. Torrey Pines Road\, La Jolla\, CA\, 92037\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260917T083000
DTEND;TZID=America/Los_Angeles:20260917T173000
DTSTAMP:20260820T210651Z
CREATED:20260820T210651Z
LAST-MODIFIED:20260820T210651Z
UID:10001160-1789633800-1789666200@www.califesciences.org
SUMMARY:Small Molecule Human PK and Dose Projection
DESCRIPTION:Join us for a comprehensive\, full-day workshop dedicated to the fundamentals and latest advancements in human pharmacokinetics (PK) and dose prediction for small molecules. This intensive event brings together leading industry experts to share scientific principles and practical strategies for translating in vitro and preclinical data to project human efficacious dose. \nThe sessions will first focus on fundamental PK parameter predictions\, covering topics such as human clearance in vitro-to-in vivo extrapolation (IVIVE)\, allometric scaling approaches\, human volume of distribution prediction\, and oral absorption\, alongside an in-depth discussion of transporter-mediated hepatobiliary and renal clearance. The workshop will also cover the integration of predicted human PK parameters and PKPD relationship to project human efficacious dose using modeling approaches\, ranging from classic compartmental models to physiologically-based PK (PBPK) and systems pharmacology models. The afternoon sessions will pivot toward human PK and dose prediction for emerging new modalities\, such as peptides and strategic design of First-in-Human (FIH) studies. Concluding with an interactive panel discussion featuring all speakers\, this workshop offers DMPK scientists\, pharmacologists\, and translational researchers a valuable platform to gain actionable insights and discuss the challenges of modern small molecule and new modality drug discovery and development. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/small-molecule-human-pk-and-dose-projection/
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Blvd\, Burlingame\, CA\, 94010\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260917T120000
DTEND;TZID=America/Los_Angeles:20260917T130000
DTSTAMP:20260824T155619Z
CREATED:20260824T155619Z
LAST-MODIFIED:20260824T155619Z
UID:10001168-1789646400-1789650000@www.califesciences.org
SUMMARY:From drug target discovery to clinical translation: Olink solutions bring value to your pipeline
DESCRIPTION:Unlocking complex disease biology requires high-sensitivity tools that work with ultra-low sample volumes. Join University Lab Partners and Olink Proteomics for an exclusive Lunch & Learn exploring how Proximity Extension Assay technology is advancing precision oncology and biomarker discovery. \nWe are honored to feature guest speaker Liya Xu\, PhD (USC Keck School of Medicine / Children’s Hospital Los Angeles)\, who will present ground-breaking research on using eye fluids as liquid biopsies to understand cancer biology. \nAgenda Highlights\nFeatured Talk: Compartmental Liquid Biopsy: Aqueous Humor as a Window into Ocular Cancer Biology \nSpeaker: Liya Xu\, PhD (Assistant Professor of Research Ophthalmology\, USC Keck School of Medicine; PI\, Aqueous Humor Laboratory\, CHLA) \nWhat You’ll Learn: \n\nHow to screen up to 5\,400 protein biomarkers using as little as 2 µL of sample\nApplications of PEA technology in challenging matrices like aqueous humor and tears\nScalable workflows: From custom disease panels to broad population screening\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-drug-target-discovery-to-clinical-translation/
LOCATION:5270 California Ave\, 5270 California Ave\, Irvine\, CA\, 92617\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260921T083000
DTEND;TZID=America/Los_Angeles:20260921T153000
DTSTAMP:20260715T194659Z
CREATED:20260715T194659Z
LAST-MODIFIED:20260715T194659Z
UID:10001125-1789979400-1790004600@www.califesciences.org
SUMMARY:From the Laboratory to Leadership | Virtual
DESCRIPTION:In the life sciences\, technical expertise often leads to a promotion into management. But leading people requires an entirely new set of skills\, and even your highest-performing scientists can struggle without the right support.  \nFrom the Laboratory to Leadership was designed specifically for this critical transition. Across four interactive sessions\, participants learn to:  \n\nDiscover and develop their leadership strengths  \n\n\nLead confidently in dynamic\, fast-paced environments  \n\n\nRun effective meetings and coach for performance  \n\n\nSet expectations\, delegate effectively\, and adapt to different personality styles  \n\n\nAmplify the performance outcomes of their teams \n\nProgram dates: September 21\, October 5\, October 19\, November 2 \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/lab-to-leadership-virtual-2026/
LOCATION:https://www.califesciences.org/event/lab-to-leadership-virtual-2026/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260924
DTSTAMP:20260727T203342Z
CREATED:20260727T203342Z
LAST-MODIFIED:20260727T203342Z
UID:10001137-1790035200-1790207999@www.califesciences.org
SUMMARY:RESI Boston 2026
DESCRIPTION:RESI Boston 2026\, a key component of Biotech Week Boston\, will take place on September 22-23 at the Westin Copley Place\, followed by three days of virtual partnering on September 25\,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions. \n\nThrough August 14\, the California Life Sciences community can save an additional $200 on RESI Boston registration. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/resi-boston-2026/
LOCATION:Westin Copley Place\, 10 Huntington Ave\, Boston\, CA\, 02116\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260922T103000
DTEND;TZID=America/Los_Angeles:20260922T113000
DTSTAMP:20260824T160149Z
CREATED:20260824T160149Z
LAST-MODIFIED:20260824T160149Z
UID:10001169-1790073000-1790076600@www.califesciences.org
SUMMARY:How to Manage Your Board Meetings and Reporting Processes
DESCRIPTION:Join University Lab Partners and Ryan Keating\, Partner at EisnerAmper\, for an in-depth webinar designed to help startup founders and emerging life sciences companies build board meeting and reporting practices that strengthen investor relationships and support smarter decision-making. \nYour board is one of your most valuable resources\, but only if you know how to run it well. Establishing clear\, repeatable processes early helps you keep investors aligned\, surface issues before they escalate\, and get real value from the people around your table. \nWhat You’ll Learn\n\nHow to structure an effective board meeting and set the right agenda\nWhat financial and operational metrics to include in your board reporting\nHow to prepare materials that keep investors informed and engaged\nPractical steps to turn board meetings into a strategic advantage\n\nAbout our Speaker\nRyan Keating\, Partner\, Eisner Advisory Group LLC \nRyan is a Partner in the firm’s Outsource Accounting Services practice. He has advised and worked with more than 120 early-stage venture capital- seeking and venture-backed companies\, several as the interim CFO. Ryan possesses an extensive financial and management consulting background from more than 20 years with venture backed companies and large technology and management consulting firms including Microsoft\, Salomon Smith Barney and PricewaterhouseCoopers. \n​Prior to Joining EisnerAmper\, Ryan was the Founder and Managing Partner of Keating Consulting Group\, a Silicon Valley-based financial professional services firm. Keating Consulting Group helped implement and manage essential function areas necessary to support early-stage companies and VC-backed startups by offering interim CFO services\, financial leadership and a full suite of accounting\, HR\, and back-office support services. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/manage-your-board-meetings-and-reporting-processes/
LOCATION:https://www.califesciences.org/event/manage-your-board-meetings-and-reporting-processes/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260922T120000
DTEND;TZID=America/Los_Angeles:20260922T160000
DTSTAMP:20260817T172155Z
CREATED:20260817T165348Z
LAST-MODIFIED:20260817T172155Z
UID:10001158-1790078400-1790092800@www.califesciences.org
SUMMARY:Discovery Bites 2026: Structural Biology in the Age of AI
DESCRIPTION:Discovery Bites 2026 is an invitation-based working lunch hosted by IRBM during Biotech Week Boston\, held inside the Harvard Art Museums. \nTopic: Structural Biology in the Age of AI. The Power of NMR Experimental Data for Smarter Drug Discovery. \nAI-driven drug discovery is only as powerful as the data behind it. As AI and structure prediction tools reshape the field\, NMR remains a uniquely powerful technique for revealing molecular insights that no other method can match. Alessandro Piai\, PhD MBA\, Head of Structural Biology at IRBM\, will speak for around 45 minutes before opening the floor to questions and discussion. \nProgram: 12:00 pm arrival and lunch\, 1:00 pm presentation\, 1:45 pm Q&A\, 2:00 pm networking.\nGuests are then welcome to explore the museum galleries. \nWho should attend: research leaders accountable for go/no-go decisions on lead and candidate series\, structural biologists and biophysicists prioritizing limited instrument time\, and CSOs\, founders and R&D executives assessing whether structural work is mission-critical. \nThere is no fee to attend. Places are limited and confirmed on a rolling basis. Registration closes September 4\, 2026. \nREGISTER \nContact: Michael Ziebell\, PhD\, Assoc. Director Business Development\, m.ziebell@irbm.com\, +1 781 579 0436.
URL:https://www.califesciences.org/event/discovery-bites-2026-structural-biology-in-the-age-of-ai/
LOCATION:Harvard Art Museum\, 32 Quincy St\, Cambridge\, MA\, 02138
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2026/02/Beyond-California-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260923T173000
DTEND;TZID=America/Los_Angeles:20260923T203000
DTSTAMP:20260817T163554Z
CREATED:20260817T163226Z
LAST-MODIFIED:20260817T163554Z
UID:10001154-1790184600-1790195400@www.califesciences.org
SUMMARY:San Diego EDC Summer Bash
DESCRIPTION:Local summer is just getting started! Join San Diego Regional EDC\, Alexandria Real Estate Equities\, Inc.\, NOVO Brazil Brewing Co.\, and a few hundred friends for EDC’s seventh annual Summer Bash on September 23. You’ll enjoy meaningful networking\, live music\, and local bites and drinks —all at Casa at Campus Point by Alexandria. \nREGISTER
URL:https://www.califesciences.org/event/san-diego-edc-summer-bash/
LOCATION:CASA Campus Point\, 4242 Campus Point Ct\, San Diego\, CA\, 92121
CATEGORIES:Community Initiatives & Programs,Industry Collaboration & Networking
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
END:VCALENDAR